The management of unicentric and multicentric Castleman's disease: A report of 16 cases and a review of the literature

Cancer

Volumn 85, Issue 3, 1999, Pages 706-717

  Bowne, Wilbur B ^a   Lewis, Jonathan J ^a   Filippa, Daniel A ^a   Niesvizky, Ruben ^a   Brooks, Ari D ^a   Burt, Michael E ^a   Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Angiofollicular lymph node hyperplasia; Castleman's disease; Management

Indexed keywords

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0033083236     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7     Document Type: Article

References (61)

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956;9:822-30.
2. Flendrig JA. Benign giant lymphoma: clinicopathologic correlation study. In: Clark RL, Cumley RW, editors. The year book of cancer, 1970. Chicago: Year Book Medical Publishers, 1970:296-99.
3. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-83.
4. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993;20:636-47.
5. Kessler E. Multicentric giant lymph node hyperplasia: a report of seven cases. Cancer 1985;56:2446-51.
6. McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev 1995;21:291-310.
7. Bartoli E, Massarelli G, Soggia G, Tanda F. Multicentric giant lymph node hyperplasia: a hyperimmune syndrome with a rapidly progressive course. Am J Clin Pathol 1980;73:423-6.
8. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86-90.
9. Herrada J, Cabanillas FF. Multicentric Castleman's disease. Am J Clin Oncol 1995;18:180-3.
10. Frizzera G. Castleman's disease: More questions than answers. Hum Pathol 1985;156:202-5.
11. Shahidi H, Myers JL, Kvale PA. Subject review: Castleman's disease. Mayo Clin Proc 1995;70:969-77.
12. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 1988;5:346-64.
13. Seco JL, Velasco F, Manuel JS, Serrano SR, Tomas L, Velasco A. Retroperitoneal Castleman's disease. Surgery 1992;112: 850-5.
14. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol 1992;5:525-30.
15. Levan T-A, Clifford S, Staren ED. Castleman's tumor masquerading as a pancreatic neoplasm. Surgery 1989;106: 804-7.
16. Humphreys SR, Holley KE, Smith LH, McIlrath DC. Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephrotic syndrome. Mayo Clin Proc 1975;50:317-21.
17. Shroff VJ, Gilchrist BF, DeLuca FG, McCombs HL, Wesselhoeft CW. Castleman's disease presenting as a pediatric surgical problem. J Pediatr Surg 1995;30:745-7.
18. Frizzera G, Massarelli G, Banks PM, Rosai J. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: pathological findings in 15 patients. Am J Surg Pathol 1983;7:211-31.
19. Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985;3:1202-16.
20. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 1985;16: 162-72.
21. Lowenthal DA, Filippa DA, Richardson ME, Bertoni M, Straus DJ. Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive man. Cancer 1987;60:2454-8.
22. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980;59:311-22.
23. Lattes R, Pachter MR. Benign lymphoid masses of probable hamartomatous nature: analysis of 12 cases. Cancer 1961; 15:197-214.
24. Scully RE, Mark EJ, McNeely WF, McNeely BU. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. N Engl J Med 1990;323:895-908.
25. Ordi J, Grau JM, Junque A, Nomdedeu B, Palacin A, Cardesa A. Secondary (AA) amyloidosis associated with Castleman's disease: report of two cases and review of the literature. Am J Clin Pathol 1993;100:394-7.
26. Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P, Lotz M. Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer 1991;69:2697-703.
27. Hsu S-M, Waldron JA, Xie S-S, Barlogie B. Expression of interleukin-6 in Castleman's disease. Hum Pathol 1993;24: 833-9.
28. Tung KSK, McCormack LJ. Angiomatous lymphoid hamartoma: report of five cases with review of the literature. Cancer 1967;20:525-36.
29. Lachant NA, Sun Nora CJ, Leong LA, Oseas RS, Prince HE. Multicentric angiofollicular lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 1985;83:27-33.
30. Oksenhendler E, Duarte M, Soulier J, Cacoub P, Welker Y, Cadranel J, et al. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 1996;10:61-7.
31. Lotz M. Interleukin-6. Cancer Invest 1993;11:732-42.
32. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-7.
33. Leger-Ravet MB, Peuchmaur M, Devergne O, Audouin J, Raphael M, Van Damme J, et al. Interleukin-6 Gene Expression in Castleman's disease. Blood 1991;78:2923-30.
34. Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin-6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990;86: 592-9.
35. Olscamp G, Weisbrod G, Sanders D, Delarue N, Mustard R. Castleman disease: unusual manifestations of an unusual disorder. Radiology 1980;135:43-8.
36. Yamashita Y, Hirai T, Matsukawa T, Ogata I, Takahashi M. Radiological presentations of Castleman's disease. Comput Med Imaging Graph 1993;17:107-17.
37. Tuttle RJ, Shier KJ. Angiography of angiomatous lymphoid hamartoma (Castleman tumor) and a suggested pathogenesis. Radiology 1979;130:311-5.
38. Walter JF, Rottenberg RW, Cannon WB, Sheridan LA, Plzzimenti J, Orr JT. Giant mediastinal lymph node hyperplasia (Castleman's disease): angiographic and clinical features. AJR Am J Roentgenol 1978;130:447-50.
39. Joseph N, Vogelzang RL, Hidvegi D, Neiman HL. Case report: computed tomography of retroperitoneal Castleman disease. J Comp Assist Tomogr 1985;9:570-2.
40. Vasef M, Katzin WE, Mendelsohn G, Reydman M. Report of a case of localized Castleman's disease with progression to malignant lymphoma. Am J Clin Pathol 1992;98:633-6.
41. Gerald W, Kostianovsky M, Rosai J. Development of vascular neoplasia in Castleman's disease: report of seven cases. Am J Surg Pathol 1990;14:603-14.
42. Weisenburger DD, DeGowin RL, Gibson P, Armitage JO. Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer 1979;44:457-62.
43. Nordstrom DG, Tewfik HH, Latourette HB. Giant lymph node hyperplasia: a review of literature and report of two cases of plasma cell variant responding to radiation therapy. Int J Radiat Oncol Biol Phys 1978;4:1045-8.
44. Fitzpatrick PJ, Brown TC. Angiofollicular lymph node hyperplasia. CMAJ 1997;99:1259-62.
45. Marti S, Pahissa A, Guardia J, Moragas A, Bacardi R. Multicentric giant follicular lymph node hyperplasia: a favorable response to radiotherapy. Cancer 1983;51:808-10.
46. Stokes SH, Griffith RC, Thomas PRM. Angiofollicular lymph node hyperplasia (Castleman's disease) associated with vertebral destruction. Cancer 1985;56:876-9.
47. Sethi T, Joshi K, Sharma SC, Gupta BD. Radiation therapy in the management of giant lymph node hyperplasia. Br J Radiol 1990;63:648-50.
48. Massey GV, Kornstein MJ, Wahl D, Huang XL, McCrady CW, Carchman RA. Angiofollicular lymph node hyperplasia (Castleman's disease) in an adolescent female: clinical and immunologic findings. Cancer 1991;68:1365-72.
49. Veldhuis GJ, van der Leest AHD, de Wolf JTM, de Vries EGE, Vellenga E. A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol 1996;73:47-50.
50. Nordstrom DG, Tewfik HH, Latourette HB. Plasma cell giant lymph node hyperplasia responding to radiation therapy. Am J Roentgenol 1978;130:169-71.
51. Beck JT, Hsu S-M, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994;330: 602-5.
52. Barbounis V, Efremidis A. A plasma cell variant of Castleman's disease treated successfully with cimetidine: case report and review of the literature. Anticancer Res 1996;16: 545-8.
53. Repetto L, Jaiprakash MP, Selby PJ, Gusterson BA, Williams HJH, Mcelwain TJ. Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantation. Hematol Oncol 1986;4:213-7.
54. Pavlidis NA, Skopouli FN, Bai MC, Bourantas CL. A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease). Med Pediatr Oncol 1990;18:333-5.
55. Summerfield GP, Taylor W, Bellingham AJ, Goldsmith HJ. Hyaline-vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids. J Clin Pathol 1997;36:1005-11.
56. Stanley MW, Frizzera G, Dehner LP. Castleman's disease, plasma cell type. Diagnosis of central nervous system involvement by cerebrospinal fluid cytology. Acta Cytol 1986; 30:481-6.
57. Tamayo M, Gonzalez C, Majado MJ, Candel R, Ramos J. Long-term complete remission after interferon treatment in a case of multicentric Castleman's disease. Am J Hematol 1995;49:359-60.
58. Donaghy M, Hall P, Gawler J, Gregson NA, Leibowitz S, Jitpimolmard S, et al. Peripheral neuropathy associated with Castleman's disease. J Neurol Sci 1989;89:253-67.
59. Stein CA, LaRocca RV, McAtee N, Myers CE. Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 1989;7:499-508.
60. Spigelman Z, Dowers A, Kennedy S, DiSorbo D, O'Brien M, Barr R, et al. Antiproliferative effects of suramin on lymphoid cells. Cancer Res 1987;47:4694-8.
61. Emson HE. Extrathoracic angiofollicular lymphoid hyperplasia with coincidental myasthenia gravis. Cancer 1973;31: 241-5.